Molina Healthcare's high P/E ratio is justified by its strong forecast growth, surpassing the wider market. Investors see insignificant potential for earnings deterioration, hence a lower P/E ratio isn't warranted. Share price drop in near future is unlikely.
Ming ling : 这些美元是给蚂蚁的吗?
F U C K : 希望很快能达到250
WOLFE (白狼) : 干得好,盈利总是比大亏损好。随时随地
74727725 : 你好。